News
Broadening capacity and support of COVID-19 products with new NC manufacturing facility
May 14, 2020
North Carolina location offers the same quick turnaround times that IDT is known for and will better support researchers in the region
CORALVILLE, Iowa (May 14, 2020) – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced the opening of its new manufacturing facility located in the Research Triangle Park in North Carolina. The facility expands IDT’s manufacturing capabilities and will offer quick turnaround time of its product portfolio to the eastern portion of the United States. In response to the COVID-19 pandemic, IDT has prepared the North Carolina facility to first manufacture products to support our customers’ efforts related to COVID-19 testing and research.
IDT’s primers and probes are important components of COVID-19 tests. The Company has produced primer and probe kits sufficient to enable more than 31 million tests to be conducted in the United States pursuant to the CDC EUA testing protocol. The new North Carolina facility further expands IDT’s capacity to serve customers and meet demand.
Widely recognized as the industry leader in DNA writing, IDT will offer custom oligonucleotides at the North Carolina facility with longer available sequence lengths and more available modifications than any other manufacturer in the region. These product options, combined with a turnaround time that can get orders into customers' hands as quickly as the next day, allows researchers to start projects sooner while taking advantage of IDT’s signature product quality.
The facility is the latest addition in IDT’s continued global expansion, joining production facilities in Coralville, Iowa, USA; San Diego, California, USA; Leuven, Belgium; and Singapore. IDT services researchers in more than 100 countries from these locations. The North Carolina facility has been equipped with IDT’s proprietary machinery and manufacturing processes, ensuring that products have the same high level of quality and consistency as those produced at all other facilities.
“The launch of our North Carolina Facility allows IDT to offer the best speed of service for East Coast and other markets, while maintaining our industry-leading product quality and 100% quality control,” said IDT President Trey Martin. “The added demand for Coronavirus-specific products means this is an opportune time for us to add new capacity, which has been configured specifically for this important purpose. The new facility will therefore immediately increase IDT’s capability to manufacture products that enable more COVID-19 testing.”
More information about IDT’s efforts to fight against COVID-19 can be found here.
IDT is an operating company within Danaher Corporation’s (NYSE: DHR) Life Sciences platform. For more information, please visit www.idtdna.com.
Follow IDT on twitter @idtdna for real-time updates and insights.
About IDT
Integrated DNA Technologies, Inc. (IDT) develops, manufactures, and markets nucleic acid products for the life sciences industry in the areas of academic and commercial research, agriculture, medical diagnostics, and pharmaceutical development. IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. Through its GMP services, IDT manufactures products used by scientists in researching many forms of cancer and most inherited and infectious diseases. IDT is widely recognized as the industry leader in custom nucleic acid manufacture, serving over 130,000 life sciences researchers. IDT was founded in 1987 and has its manufacturing headquarters in Coralville, Iowa, USA, with additional manufacturing sites in San Diego, California, USA; Research Triangle Park, North Carolina, USA; Leuven, Belgium; and Singapore. For more information, please visit www.idtdna.com.
Media Contacts
IDT Public Relations
800-328-2661 (US & Canada)
+1 319-626-8400 (outside US)
idtpr@idtdna.com
About Danaher Corporation
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, including IDT, Danaher’s globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and our Shared Purpose, Helping Realize Life’s Potential. For more information, please visit www.danaher.com
CORALVILLE, Iowa (May 14, 2020) – Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, announced the opening of its new manufacturing facility located in the Research Triangle Park in North Carolina. The facility expands IDT’s manufacturing capabilities and will offer quick turnaround time of its product portfolio to the eastern portion of the United States. In response to the COVID-19 pandemic, IDT has prepared the North Carolina facility to first manufacture products to support our customers’ efforts related to COVID-19 testing and research.
IDT’s primers and probes are important components of COVID-19 tests. The Company has produced primer and probe kits sufficient to enable more than 31 million tests to be conducted in the United States pursuant to the CDC EUA testing protocol. The new North Carolina facility further expands IDT’s capacity to serve customers and meet demand.
Widely recognized as the industry leader in DNA writing, IDT will offer custom oligonucleotides at the North Carolina facility with longer available sequence lengths and more available modifications than any other manufacturer in the region. These product options, combined with a turnaround time that can get orders into customers' hands as quickly as the next day, allows researchers to start projects sooner while taking advantage of IDT’s signature product quality.
The facility is the latest addition in IDT’s continued global expansion, joining production facilities in Coralville, Iowa, USA; San Diego, California, USA; Leuven, Belgium; and Singapore. IDT services researchers in more than 100 countries from these locations. The North Carolina facility has been equipped with IDT’s proprietary machinery and manufacturing processes, ensuring that products have the same high level of quality and consistency as those produced at all other facilities.
“The launch of our North Carolina Facility allows IDT to offer the best speed of service for East Coast and other markets, while maintaining our industry-leading product quality and 100% quality control,” said IDT President Trey Martin. “The added demand for Coronavirus-specific products means this is an opportune time for us to add new capacity, which has been configured specifically for this important purpose. The new facility will therefore immediately increase IDT’s capability to manufacture products that enable more COVID-19 testing.”
More information about IDT’s efforts to fight against COVID-19 can be found here.
IDT is an operating company within Danaher Corporation’s (NYSE: DHR) Life Sciences platform. For more information, please visit www.idtdna.com.
Follow IDT on twitter @idtdna for real-time updates and insights.
About IDT
Integrated DNA Technologies, Inc. (IDT) develops, manufactures, and markets nucleic acid products for the life sciences industry in the areas of academic and commercial research, agriculture, medical diagnostics, and pharmaceutical development. IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. Through its GMP services, IDT manufactures products used by scientists in researching many forms of cancer and most inherited and infectious diseases. IDT is widely recognized as the industry leader in custom nucleic acid manufacture, serving over 130,000 life sciences researchers. IDT was founded in 1987 and has its manufacturing headquarters in Coralville, Iowa, USA, with additional manufacturing sites in San Diego, California, USA; Research Triangle Park, North Carolina, USA; Leuven, Belgium; and Singapore. For more information, please visit www.idtdna.com.
Media Contacts
IDT Public Relations
800-328-2661 (US & Canada)
+1 319-626-8400 (outside US)
idtpr@idtdna.com
About Danaher Corporation
Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world. Its family of world class brands has leadership positions in the demanding and attractive health care, environmental and applied end-markets. With more than 20 operating companies, including IDT, Danaher’s globally diverse team of approximately 71,000 associates is united by a common culture and operating system, the Danaher Business System, and our Shared Purpose, Helping Realize Life’s Potential. For more information, please visit www.danaher.com
Media and PR
For media inquiries please contact IDT Public Relations, idtpr@idtdna.com